Biophytis (EPA:ALBPS) | WebDisclosure

Basculer en Français

11294	Companies
250971	Keywords
179884	Articles
136841	Press releases

Home
Companies
Biophytis

REGULATED PRESS RELEASE

published on 08/28/2025 at 07:00, 1 year 2 months ago

Biophytis obtient l’autorisation de l’EMA et des autorités belges pour démarrer son essai clinique de phase 3 dans la sarcopénie
Biophytis obtient l’autorisation de l’EMA et des autorités belges pour démarrer son essai clinique de phase 3 dans la sarcopénie. La société se prépare à recruter des patients pour cette étude majeure

Biophytis Essai Clinique Sarcopénie Autorisation EMA
PRESS RELEASE

published on 08/28/2025 at 06:59, 1 year 2 months ago

Biophytis obtient l’autorisation de l’EMA et des autorités belges pour démarrer son essai clinique de phase 3 dans la sarcopénie
Biophytis obtient l’autorisation de l’EMA et des autorités belges pour démarrer son essai clinique de phase 3 dans la sarcopénie. Étape majeure dans le développement de thérapies pour la perte musculaire liée à l’âge

Biophytis Essai Clinique Sarcopénie Autorisation EMA
PRESS RELEASE

published on 08/28/2025 at 06:59, 1 year 2 months ago

Biophytis Receives EMA and Belgian Regulatory Approval to Initiate Phase 3 Sarcopenia Clinical Trial
Biophytis receives EMA and Belgian regulatory approval for Phase 3 sarcopenia clinical trial, enabling patient enrolment in Belgium and collaboration with European centers

Biophytis Sarcopenia Phase 3 EMA Approval Belgian Regulatory Approval
BRIEF

published on 08/05/2025 at 23:05, 1 year 3 months ago

Biophytis assure 1 million d'euros de financement obligataire

Biophytis Dilution Actionnaires Financement Obligataire Hexagon Capital Fund OBA101 Développement
BRIEF

published on 08/05/2025 at 23:05, 1 year 3 months ago

Biophytis Secures €1 Million Non-Dilutive Bond Financing

Biophytis Bond Financing Shareholder Impact Non-dilutive OBA101 Program
REGULATED PRESS RELEASE

published on 08/05/2025 at 23:00, 1 year 3 months ago

Biophytis sécurise une ligne de financement obligataire non dilutive jusqu’à 1 M€
Biophytis sécurise une ligne de financement obligataire non dilutive jusqu’à 1 M€ avec Hexagon Capital Fund pour financer le programme OBA101 et couvrir ses besoins jusqu’au premier trimestre 2026

Biophytis Trésorerie Financement Obligataire Hexagon Capital Fund OBA101
REGULATED PRESS RELEASE

published on 08/05/2025 at 23:00, 1 year 3 months ago

Biophytis Secures Non-Dilutive Bond Financing Line of up to €1 Million
Biophytis secures a non-dilutive bond financing line of up to €1 million with Hexagon Capital Fund to support OBA101 program development and strengthen cash position

Biophytis Financing Hexagon Capital Fund OBA101 Program Non-dilutive Bond
PRESS RELEASE

published on 08/05/2025 at 22:59, 1 year 3 months ago

Biophytis sécurise une ligne de financement obligataire non dilutive jusqu’à 1 M€
Biophytis sécurise une ligne de financement obligataire non dilutive de 1 M€ avec Hexagon Capital Fund pour financer le développement clinique du programme OBA101 jusqu'au T1 2026

Biophytis Obligataire Hexagon Capital Fund Ligne De Financement Dilutive
PRESS RELEASE

published on 08/05/2025 at 22:59, 1 year 3 months ago

Biophytis Secures Non-Dilutive Bond Financing Line of up to €1 Million
Biophytis secures a non-dilutive bond financing line of up to €1 million from Hexagon Capital Fund. The bonds, with 12% annual interest rate, will mature in 24 months and may be repaid in shares

Biophytis Hexagon Capital Fund Non-dilutive Bond Financing 12% Interest Rate Repayment In Shares
BRIEF

published on 07/30/2025 at 07:05, 1 year 3 months ago

Biophytis Joins Silver Innov' to Boost Silver Economy Initiatives

Biophytis Healthcare Innovation Longevity Sarcopenia Silver Innov'

Accesswire

Published on 11/06/2026 at 22:15, 2 days 8 hours ago

Jaguar Health Reports Approval of All Proposals at November 2026 Special Meeting of Stockholders
Published on 11/06/2026 at 13:00, 2 days 17 hours ago

Alaska Energy Metals Achieves High Extraction Rates of Metals from Hydromet Testing, Nikolai Nickel Project, Alaska
Published on 11/06/2026 at 12:30, 2 days 18 hours ago

Relevant Gold Receives Expanded Drilling Approvals for the Lewiston Project in Wyoming
Published on 11/06/2026 at 12:30, 2 days 18 hours ago

Vogenx Reports Third Quarter 2026 Financial Results and Business Highlights
Published on 11/06/2026 at 10:00, 2 days 20 hours ago

Mongolia Tax Audit

View all ACCESSWIRE

EQS Group

Published on 11/09/2026 at 01:55, 4 hours 45 minutes ago

EQS-Adhoc: NEXTDC Limited: Response to Statement by Goodman Group & Digital Realty
Published on 11/08/2026 at 12:10, 18 hours 30 minutes ago

GSMA MWC26 Doha opens with call to align on global industry standards and close MENA's connectivity gap
Published on 11/08/2026 at 10:15, 20 hours 25 minutes ago

2026 China International Intelligent Communication Forum Held in Wuxi
Published on 11/07/2026 at 13:35, 1 day 17 hours ago

Eurobattery Minerals board member and CEO remanded in custody in Sweden
Published on 11/06/2026 at 20:15, 2 days 10 hours ago

African Medicines Agency Marks First Year of Operations with New Platforms to Strengthen Regulation and Support Manufacturing

Les Echos

Published on 11/06/2026 at 19:06, 2 days 11 hours ago

ALTAREIT : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES OCTOBRE 2026
Published on 11/06/2026 at 19:04, 2 days 11 hours ago

ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 11/06/2026 at 19:01, 2 days 11 hours ago

ALTAREA : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES OCTOBRE 2026
Published on 11/06/2026 at 19:00, 2 days 11 hours ago

ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 11/06/2026 at 18:00, 2 days 12 hours ago

ICADE - CP - Notation crédit S&P

View all LES ECHOS COMFI WIRE